论文部分内容阅读
目的对左卡尼汀配合透析治疗尿毒症患者的疗效进行分析。方法随机抽取2009年10月~2011年10月期间的尿毒症患者86例,在患者同意的情况下随机分为对照组和实验组两组,各43例患者。对对照组中的尿毒症患者采取常规的血液透析治疗,而对观察组中患者采取左卡尼汀配合透析治疗。对两组患者的临床疗效进行比较。结果相对于对照组,观察组中的尿毒症患者的贫血以及白蛋白、血浆总蛋白水平改善情况更为良好,P<0.05。结论在对尿毒症患者进行疾病治疗时,采取左卡尼汀配合透析治疗方式使得临床效果更为良好。
Objective To analyze the efficacy of levocarnitine in combination with dialysis in patients with uremia. Methods Totally 86 patients with uremia were selected from October 2009 to October 2011, and randomly divided into control group and experimental group (43 cases) with consent of patients. Uremic patients in the control group were treated with conventional hemodialysis while patients in the observation group were treated with levocarnitine and dialysis. The clinical efficacy of the two groups were compared. Results Compared with the control group, uremia patients in the observation group showed better improvement of anemia, albumin and total plasma protein (P <0.05). Conclusions In the treatment of uremic patients, the clinical effect of L-carnitine combined with dialysis therapy is better.